Effects of the Oral Care With Vaccines for Pneumonia in Elderly; Going Home Together Both Physician and Dentist

Not Applicable

Completed

• Conditions: Pneumonia
• Interventions: Biological: Pneumococcal vaccination (Pneumovax NP, 21800AMY10131000); Biological: Influenza vaccination (Flubik HA, 16100EZZ01207000); Other: Specific frequency of oral care

• Registration Number: NCT01403805
• Lead Sponsor: Yubari Kibounomori

Brief Summary

Prospective study comparing the effects of interventions (combined oral care and pneumococcal plus influenza vaccinations) in preventing pneumonia and increasing the survival rate from pneumonia.

Detailed Description

The elderly population can be expected to increase not only in developed countries, but also in developing countries. Pneumonia is one of the most common causes of death in the elderly.

The investigators conducted a prospective study comparing the effects of interventions (combined oral care and pneumococcal plus influenza vaccinations) in preventing pneumonia and increasing the survival rate from pneumonia in consecutive elderly patients at a nursing home in Yubari during one year from 2009, with the results in a non-intervention group.

Study Timeline

• Study Start: 2009-11
• Primary Completion: 2010-10
• Study Completion: 2010-10
• Study First Submitted: 2011-07-25
• Study First Submitted QC: 2011-07-26
• Study First Posted: 2011-07-27
• Results First Submitted: 2011-08-02
• Status Verified: 2012-04
• Results First Submitted QC: 2012-04-29
• Last Update Submitted: 2012-04-29
• Results First Posted: 2012-05-01
• Last Update Posted: 2012-05-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 199

Inclusion Criteria

• The residents or an agent who understand the purpose of this study and give informed consent.

Exclusion Criteria

• The residents contraindicated to vaccine

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Oral care and vaccines	Pneumococcal vaccination (Pneumovax NP, 21800AMY10131000)	Oral care and pneumococcal plus influenza vaccines
Oral care and vaccines	Influenza vaccination (Flubik HA, 16100EZZ01207000)	Oral care and pneumococcal plus influenza vaccines
Oral care and vaccines	Specific frequency of oral care	Oral care and pneumococcal plus influenza vaccines
Vaccine	Influenza vaccination (Flubik HA, 16100EZZ01207000)	Influenza vaccine only

Primary Outcome Measures

Name	Time	Method
Number of Participants With Pneumonia	1 year	Number of Participants with Pneumonia sufferers

Secondary Outcome Measures

Name	Time	Method
Death From Pneumonia	1 year	Number of participants for the death from pneumonia

Trial Locations

Locations (1)

Yubari Kibounomori; 🇯🇵 Yubari, Hokkaido, Japan